Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: -0.05 (-1.52%)
Spread: 0.10 (3.125%)
Open: 3.30
High: 3.30
Low: 3.25
Prev. Close: 3.30
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks head higher as pound tops USD1.28 again

Fri, 16th Jun 2023 08:47

(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions.

The FTSE 100 index opened up 25.03 points, 0.3%, at 7,653.27. The FTSE 250 was up 47.47 points, 0.3%, at 19,086.88, and the AIM All-Share was up 2.50 points, 0.3%, at 794.06.

The Cboe UK 100 was up 0.3% at 763.65, the Cboe UK 250 was 0.2% at 16,654.07, and the Cboe Small Companies was up 0.2% at 13,923.00.

"The UK market is on its own streak this week, with yesterday marking the fourth consecutive session of gains as investors try and make heads or tails of mixed data from around the globe," said Hargreaves Lansdown's Matt Britzman.

In a week dominated by central bank decisions elsewhere, market attention is shifting to the BoE's own decision next Thursday. The pound continued its upward trajectory, as sticky inflation data, combined with strong employment and economic growth prints, set the stage for the BoE to continue its rate-hiking cycle.

Sterling was quoted at USD1.2788 early Friday, rising from USD1.2759 at the London equities close on Thursday. The pound had risen past the USD1.28 mark shortly after Friday's equity market open in London. Sterling traded at its best level since April 2022.

The latest central bank decision came from the Bank of Japan, which said it would maintain its long-standing, ultra-loose monetary policy as it looks to boost economic growth.

It left its negative interest rate in place and did not adjust the band in which rates for 10-year government bonds fluctuate, a scheme known as yield curve control

Against the yen, the dollar was quoted at JPY140.74, up versus JPY140.52.

Officials had been widely expected to keep policies unchanged after the second two-day meeting chaired by new Governor Kazuo Ueda.

The central bank has gone against the grain as its global peers hike interest rates to tackle inflation, pushing down the value of the yen against the dollar.

The Nikkei 225 index in Tokyo closed up 0.7%, consolidating recent highs on the back of the weak yen.

"The overbought market conditions, and the idea that Japan will, one day in our lifetime, normalize rates could lead to some profit taking, but it's also true that companies in geopolitically sensitive sectors like defence and semiconductors have been major drivers of the rally this year, and there is no reason for that appetite to change when the geopolitical landscape remains this tense," said Swissquote Bank's Ipek Ozkardeskaya.

In China, the Shanghai Composite was up 0.3%, while the Hang Seng index in Hong Kong was up 1.4%. The S&P/ASX 200 in Sydney closed up 1.1%.

Asian equities got a boost after China's central bank cut a key interest rate and injected USD33 billion into financial markets on Thursday. This comes after recent data suggested the country's economic recovery was flagging.

Gold was quoted at USD1,961.01 an ounce early Friday, up from USD1,955.88 on Thursday. Brent oil fetched USD75.75 a barrel, rising from USD74.81.

In European equities on Friday, the CAC 40 in Paris was up 0.1%, while the DAX 40 in Frankfurt was flat.

The euro traded at USD1.0952 early Friday, higher than USD1.0930 late Thursday.

The ECB lifted interest rates in the eurozone by 25 basis points, as expected, on Thursday. The Frankfurt-based central bank acknowledged in its statement on Thursday that inflation has been coming down, but is nonetheless projected to remain "too high for too long".

ECB President Christine Lagarde said a pause was not even an option for the ECB. Her words suggest a hike in July is all but assured, and that the September meeting is also a live one.

Stocks on Wall Street rallied on Thursday, despite hawkish rhetoric from the US Federal Reserve, with the Dow Jones Industrial Average up 1.3%, while the S&P 500 and the Nasdaq Composite both rose 1.2%.

The Federal Reserve left interest rates unchanged on Wednesday but signalled further increases were on the way before the end of the year. But with US two-year Treasury yields narrowing to around 4.65% late Thursday, from 4.69% ahead of the Fed decision on Wednesday, there is a sign some investors are not buying the central bank's hawkish narrative.

In London's FTSE 100 index, Tesco fell 1.1%

The company said it was seeing signs that inflation is easing in the grocery market, and the supermarket chain backed annual guidance as it kicked off its financial year with a sales hike.

Tesco said revenue in the 13 weeks to May 27, its first quarter, rose 9.4% to GBP15.17 billion. The measure excludes both VAT and fuel, but includes Tesco Bank.

Looking ahead, Tesco said it still expects retail free cash flow within its GBP1.4 billion to GBP1.8 billion target range. At best, this would be a 16% fall from GBP2.13 billion in financial 2023.

It still expects a "broadly flat level" of retail adjusted operating profit. Retail adjusted operating profit fell 6.1% to GBP2.49 billion from GBP2.65 billion in financial 2023.

"Tesco is managing the weakening consumer landscape about as well as possible. That's being helped by the group's enormous scale... The mature, deeply rooted, nature of its relationships has been a key tool in helping to keep prices down," said HL's Aarin Chiekrie.

Meanwhile, among mid-caps, Travis Perkins slumped 7.6%.

The builders' merchant said it had delivered a "resilient" performance in the first quarter of 2023, but it has not seen the anticipated easing of market conditions in the second quarter to date.

"Volumes in both the new build housing and private domestic RMI markets continue to be impacted by higher interest rates and weaker consumer confidence driven by persistent, higher than anticipated consumer price inflation," Travis Perkins said.

ITV fell 0.6%. The media company and broadcaster confirmed a Reuters report from Thursday that it is considering an acquisition of production group All3Media. All3Media is jointly owned by Warner Bros Discovery and Liberty Global. According to Reuters sources, ITV is considering combining the business with its Studios unit, and Liberty Global could possibly retain a stake. As well as jointly-owning All3Media, Liberty Global has a roughly 9.9% stake in ITV.

Reuters had previously reported All3Media, which produces Fleabag and Midsomer Murders, could fetch a price tag over GBP1 billion.

On AIM, ValiRx fell 15%

The life sciences company, which focuses on early-stage cancer therapeutics and women's health, said it has concluded its evaluation agreement with Hokkaido University.

"Under this agreement, ValiRx committed to conducting a range of experiments following initial confirmation of the synthetic route and analysis. After overcoming initial challenges in synthesis and purification of the peptide, testing has been conducted on the product," it explained.

The product was subsequently found to be "unsuitable" for further development, and the evaluation will now end.

Still to come on Friday's economic calendar, there's a eurozone inflation reading at 1000 BST.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.